Top-News
Biotechnologie Frankreich

Neovacs SA News

Aktie
WKN:  A400CN ISIN:  FR001400MV37
0,22 €
+0,2197 €
+73.233,33%
20:13:47 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
350,00 Tsd.
Marktkapitalisierung *
184,98 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 06.02.2024

Neovacs SA News

06.12.19 - GlobeNewswire
OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS
13.11.19 - GlobeNewswire
NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANY
02.10.19 - GlobeNewswire
NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS
30.09.19 - GlobeNewswire
NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICER
PRESS RELEASE · PRESS RELEASE   · PRESS RELEASE
09.09.19 - GlobeNewswire
Neovacs : 2019 Financial Calendar
09.07.19 - GlobeNewswire
NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE FIRST PAYMENT OF THE ANR GRANT
27.06.19 - GlobeNewswire
NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR
05.06.19 - GlobeNewswire
Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's 79th scientific sessions
16.05.19 - GlobeNewswire
Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma
09.04.19 - GlobeNewswire
Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus - 13th International Lupus Congress 2019
05.04.19 - GlobeNewswire
2019 Financial Calendar
01.04.19 - GlobeNewswire
Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE
27.03.19 - GlobeNewswire
NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
25.03.19 - GlobeNewswire
Neovacs reports full-year 2018 Financial results and provides corporate update
RESS RELEASE · PRESS RELEASE   · PRESS RELEASE
21.03.19 - GlobeNewswire
Neovacs to present the preclinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid at Keystone Congress
20.02.19 - GlobeNewswire
Neovacs announces two appointments to its executive committee
05.02.19 - GlobeNewswire
Neovacs to host KOL Meeting to discuss its therapeutic vaccin IFNalpha Kinoid for lupus treatment - February 11th Paris
31.01.19 - GlobeNewswire
Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
24.01.19 - GlobeNewswire
Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE
08.01.19 - GlobeNewswire
NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE IL-4/IL-13 KINOID AS AN ALLERGY TREATMENT
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS SECURES FINANCING FROM THE ANR - THE FRENCH NATIONAL RESEARCH AGENCY - TO DEVELOP THE ...

Newssuche

Videos

08:55 Uhr +2,22%
Technical Trading: Rohöl Short Chance
Rohöl Short Typ: Turbo Open End WKN: VD4JF9 Hebel: 13 Laufzeit: OpenEnd Einstieg: Market ... Mehr »